Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives of this study are: • To determine the efficacy of treatment with SOF + RBV as measured by the proportion of subjects with sustained viral response 12 weeks after discontinuation of therapy (SVR12) • To evaluate the safety and tolerability of SOF + RBV as assessed by review of the accumulated safety data, including HIV-RNA and CD4 T-cell percent
Inclusion criteria
- Hepatitis C Virus Infection